Dose uncertainty in radiotherapy of patients with head and neck cancer measured byin vivoESR/alanine dosimetry using a mouthpiece
- 4 February 2011
- journal article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 56 (5), 1373-1383
- https://doi.org/10.1088/0031-9155/56/5/010
Abstract
In order (i) to evaluate the dose uncertainty of the mouthpiece in daily use during intensity-modulated radiotherapy of patients with head and neck cancer, and (ii) to present a system for in vivo dosimetry of the oral mucosa, we equipped the mouthpiece with alanine dosimeter probes for in vivo dosimetry. The aim was to determine the dose uncertainty caused by the daily positioning of the mouthpiece during dynamic treatment techniques. During IMRT radiotherapy of patients with head and neck cancer, the doses accumulated next to the mucosa were measured in five patients and compared to the dose calculated by the treatment planning system. The comparison of the applied and measured dose for each measurement point showed in six of the eight alanine probe positions a good agreement within the given relative combined standard uncertainty of less than 4.5% for a accumulated dose of 30 Gy and less than 4.6% for an accumulated dose of 8 Gy, respectively. In two of the eight alanine probe positions the applied and measured doses differed by 7.7% and 8.2% from each other. The dominant contribution to the overall uncertainty for the in vivo measurements was the positioning of the dosimeter probes in the patient's body and their corresponding localization in the CT data as well as the inaccuracy of the available algorithm for dose distribution calculation at the low-density material/soft tissue interface between the mouthpiece and the mucosa. Regarding our results, we refrain from the use of a mouthpiece during dynamic treatments such as IMRT.This publication has 24 references indexed in Scilit:
- An absolute dose determination of helical tomotherapy accelerator, TomoTherapy High-Art IIMedical Physics, 2009
- In vivodosimetry in the urethra using alanine/ESR during192Ir HDR brachytherapy of prostate cancer—a phantom studyPhysics in Medicine & Biology, 2009
- Is there an influence of the surrounding material on the response of the alanine dosimetry system?Physics in Medicine & Biology, 2009
- Response of the alanine/ESR dosimetry system to MV x-rays relative to60Co radiationPhysics in Medicine & Biology, 2008
- Postirradiation effects in alanine dosimeter probes of two different suppliersPhysics in Medicine & Biology, 2008
- Relative output factor and beam profile measurements of small radiation fields with an L‐alanine/K‐Band EPR minidosimeterMedical Physics, 2007
- Uncertainties in alanine/ESR dosimetry at the Physikalisch-Technische BundesanstaltPhysics in Medicine & Biology, 2006
- Development of a secondary standard for the absorbed dose to water based on the alanine EPR dosimetry systemApplied Radiation and Isotopes, 2005
- Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized TrialJournal of Clinical Oncology, 2005
- Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancerCancer, 1990